IBDEI1O9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28406,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28406,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,28406,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,28407,0)
 ;;=I48.1^^112^1419^21
 ;;^UTILITY(U,$J,358.3,28407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28407,1,3,0)
 ;;=3^Persistent Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28407,1,4,0)
 ;;=4^I48.1
 ;;^UTILITY(U,$J,358.3,28407,2)
 ;;=^5007225
 ;;^UTILITY(U,$J,358.3,28408,0)
 ;;=I48.2^^112^1419^9
 ;;^UTILITY(U,$J,358.3,28408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28408,1,3,0)
 ;;=3^Chronic Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,28408,1,4,0)
 ;;=4^I48.2
 ;;^UTILITY(U,$J,358.3,28408,2)
 ;;=^5007226
 ;;^UTILITY(U,$J,358.3,28409,0)
 ;;=I48.92^^112^1419^6
 ;;^UTILITY(U,$J,358.3,28409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28409,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,28409,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,28409,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,28410,0)
 ;;=I48.3^^112^1419^24
 ;;^UTILITY(U,$J,358.3,28410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28410,1,3,0)
 ;;=3^Typical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,28410,1,4,0)
 ;;=4^I48.3
 ;;^UTILITY(U,$J,358.3,28410,2)
 ;;=^5007227
 ;;^UTILITY(U,$J,358.3,28411,0)
 ;;=I48.4^^112^1419^7
 ;;^UTILITY(U,$J,358.3,28411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28411,1,3,0)
 ;;=3^Atypical Atrial Flutter
 ;;^UTILITY(U,$J,358.3,28411,1,4,0)
 ;;=4^I48.4
 ;;^UTILITY(U,$J,358.3,28411,2)
 ;;=^5007228
 ;;^UTILITY(U,$J,358.3,28412,0)
 ;;=Z71.89^^112^1420^1
 ;;^UTILITY(U,$J,358.3,28412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28412,1,3,0)
 ;;=3^Counseling,Other Specified
 ;;^UTILITY(U,$J,358.3,28412,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,28412,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,28413,0)
 ;;=Z71.7^^112^1420^2
 ;;^UTILITY(U,$J,358.3,28413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28413,1,3,0)
 ;;=3^HIV Counseling
 ;;^UTILITY(U,$J,358.3,28413,1,4,0)
 ;;=4^Z71.7
 ;;^UTILITY(U,$J,358.3,28413,2)
 ;;=^5063251
 ;;^UTILITY(U,$J,358.3,28414,0)
 ;;=Z76.89^^112^1420^4
 ;;^UTILITY(U,$J,358.3,28414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28414,1,3,0)
 ;;=3^Persons Encountering Health Services for Oth Circumstances
 ;;^UTILITY(U,$J,358.3,28414,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,28414,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,28415,0)
 ;;=Z01.812^^112^1420^3
 ;;^UTILITY(U,$J,358.3,28415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28415,1,3,0)
 ;;=3^Lab Result Counseling
 ;;^UTILITY(U,$J,358.3,28415,1,4,0)
 ;;=4^Z01.812
 ;;^UTILITY(U,$J,358.3,28415,2)
 ;;=^5062627
 ;;^UTILITY(U,$J,358.3,28416,0)
 ;;=E03.9^^112^1421^25
 ;;^UTILITY(U,$J,358.3,28416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28416,1,3,0)
 ;;=3^Hypothroidism,Unspec
 ;;^UTILITY(U,$J,358.3,28416,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,28416,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,28417,0)
 ;;=E11.9^^112^1421^22
 ;;^UTILITY(U,$J,358.3,28417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28417,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,28417,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,28417,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,28418,0)
 ;;=E10.9^^112^1421^6
 ;;^UTILITY(U,$J,358.3,28418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28418,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,28418,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,28418,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,28419,0)
 ;;=E11.65^^112^1421^15
 ;;^UTILITY(U,$J,358.3,28419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28419,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
